Robb E. Wilentz
Impact in
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Ralph H. Hruban (41 shared papers)Charles J. Yeo (27 shared papers)John L. Cameron (16 shared papers)Michael Goggins (16 shared papers)Scott E. Kern (17 shared papers)Taylor A. Sohn (12 shared papers)Christine A. Iacobuzio–Donahue (9 shared papers)Pedram Argani (10 shared papers)
- Journals
- American Journal Of Pathology (8 papers)American Journal of Clinical Pathology (7 papers)The American Journal of Surgical Pathology (6 papers)Modern Pathology (5 papers)Cancer (3 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Robb E. Wilentz
61 papers receiving 7.1k citations
Robb E. Wilentz's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 4.9k
- Cancer Research 1.5k
- Surgery 2.2k
- Pathology and Forensic Medicine 692
- Molecular Biology 2.1k
Countries citing papers authored by Robb E. Wilentz
This map shows the geographic impact of Robb E. Wilentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robb E. Wilentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robb E. Wilentz more than expected).
Fields of papers citing papers by Robb E. Wilentz
This network shows the impact of papers produced by Robb E. Wilentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robb E. Wilentz. The network helps show where Robb E. Wilentz may publish in the future.
Co-authors
The 25 scholars most cited alongside Robb E. Wilentz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Hit paper breakdown → | 2001 | 492 |
| 2 | Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. | 2000 | 472 |
| 3 | 2002 | 380 | |
| 4 | 2000 | 307 | |
| 5 | 2002 | 289 | |
| 6 | Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. | 2001 | 283 |
| 7 | Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. | 1998 | 277 |
| 8 | 2003 | 273 | |
| 9 | 2002 | 269 | |
| 10 | 2000 | 263 | |
| 11 | The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. | 2001 | 251 |
| 12 | 2002 | 240 | |
| 13 | Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. | 2001 | 237 |
| 14 | 2002 | 214 | |
| 15 | Mucinous cystic neoplasms of the pancreas. | 2000 | 209 |
| 16 | 2000 | 207 | |
| 17 | 2000 | 201 | |
| 18 | 1999 | 186 | |
| 19 | 2002 | 181 | |
| 20 | 2002 | 143 |
About Robb E. Wilentz
Robb E. Wilentz is a scholar working on Oncology, Surgery, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 61 papers that have together received 7.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (43 papers), Genetic factors in colorectal cancer (14 papers), Cancer Genomics and Diagnostics (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Pancreatitis Pathology and Treatment (9 papers), Neuroendocrine Tumor Research Advances (7 papers), Epigenetics and DNA Methylation (6 papers) and TGF-β signaling in diseases (5 papers). The work is most often cited by research in Oncology (4.9k citations), Cancer Research (1.5k citations), Surgery (2.2k citations), Pathology and Forensic Medicine (692 citations) and Molecular Biology (2.1k citations). Robb E. Wilentz has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Ralph H. Hruban, Charles J. Yeo, John L. Cameron, Michael Goggins, Scott E. Kern, Taylor A. Sohn, Christine A. Iacobuzio–Donahue, Pedram Argani, S E Kern and Christophe Rosty. Their work appears in journals such as American Journal Of Pathology, American Journal of Clinical Pathology, The American Journal of Surgical Pathology, Modern Pathology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.